Pliant Therapeutics Inc (PLRX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.29
• Market Cap: $78.66M
• EPS: $-2.86
• 52-Week High: $3.46
• 52-Week Low: $1.09

Market Sentiment

Pliant Therapeutics Inc currently has a Neutral sentiment score of 0.10.

About Pliant Therapeutics Inc

Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to the discovery and development of innovative therapies for fibrosis and related diseases. The company is advancing a robust pipeline that includes treatments for conditions such as idiopathic pulmonary fibrosis, reflecting its commitment to addressing critical unmet medical needs in this area. Leveraging its deep expertise in fibroblast biology and small molecule drug ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Pliant Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PLRX pay dividends?

Pliant Therapeutics Inc (PLRX) does not currently pay a regular dividend.

What is PLRX's market cap?

Pliant Therapeutics Inc (PLRX) has a market capitalization of $78.66M with a current stock price of $1.29.